Nana Sasaki

Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia

Mio Yamamoto‐Sugitani, Junya Kuroda, Eishi Ashihara et al. · Proceedings of the National Academy of Sciences · 2011 · 99 citations · Full text

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

Tsutomu Kobayashi, Junya Kuroda, Eishi Ashihara et al. · Leukemia · 2010 · 98 citations

Hematological Malignancy, Malignant Blood Disorder, Immunology +7

Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia

Junya Kuroda, Mio Yamamoto, Hisao Nagoshi et al. · Molecular Cancer Research · 2010 · 76 citations

Mixed-phenotype Acute Leukemia, Apoptosis, Immunology +19

Cyclosporine A for Chemotherapy-Resistant Subcutaneous Panniculitis-Like T Cell Lymphoma with Hemophagocytic Syndrome

Shinsuke Mizutani, Junya Kuroda, Yuji Shimura et al. · Acta Haematologica · 2011 · 40 citations

Immunodeficiencies, Immunology, Pathology +17

Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression

Nana Sasaki, Junya Kuroda, Hisao Nagoshi et al. · Experimental Hematology · 2011 · 33 citations · Full text

B-cell Lymphoma, Lymphoid Neoplasia, Concurrent Bcl-2 +9